Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90 CHF | +0.99% | +6.48% | +6.04% |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Apr. 24 | Novartis Says New Malaria Drug Formulation Safe and Effective for Babies | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
90 CHF | +0.99% | +6.48% | 199B | ||
16.66 EUR | +8.18% | +12.57% | 32.44B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.04% | 199B | |
+24.17% | 562B | |
-6.41% | 358B | |
+18.78% | 322B | |
+7.70% | 297B | |
+13.45% | 219B | |
-10.51% | 196B | |
-11.29% | 149B | |
-6.87% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Deutsche Bank keeps a Sell rating